Advertisement

Academic Psychiatry

, Volume 29, Issue 5, pp 500–501 | Cite as

The Association of Pharmaceutical Company Promotional Spending With Resident Physician Prescribing Behavior

  • Frederick Y. Huang
  • Daniel S. Weiss
  • Paul G. Fenimore
  • Anne M. Fleming
  • Ellen Haller
  • Jonathan E. Lichtmacher
  • Stuart J. Eisendrath
Letters

Keywords

Pharmaceutical Company Academic Psychiatry Residency Training Resident Physician Psychiatry Residency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Zuger A: Fever pitch: getting doctors to prescribe is big business. New York Times, 1999Google Scholar
  2. 2.
    Drake D, Uhlman M: Making Medicine, Making Money. Kansas City, Andrews and McMeel, 1993Google Scholar
  3. 3.
    Chren MM, Landefeld CS: Physicians’ behavior and their interactions with drug companies: a controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994; 271: 684–689PubMedCrossRefGoogle Scholar
  4. 4.
    Bowman MA, Pearle DL: Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Contin Educ Health Prof 1988; 8: 13–20PubMedCrossRefGoogle Scholar
  5. 5.
    Steinman MA, Shlipak MG, McPhee SJ: Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001; 110: 551–557PubMedCrossRefGoogle Scholar
  6. 6.
    Lurie N, Rich EC, Simpson DE, et al: Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med 1990; 5: 240–243PubMedCrossRefGoogle Scholar
  7. 7.
    Kowalczyk L: Massachusetts General moves to curb drugven-dors. Boston Globe, 2002Google Scholar
  8. 8.
    McCormick BB, Tomlinson G, Brill-Edwards P, et al: Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001; 286: 1994–1999PubMedCrossRefGoogle Scholar
  9. 9.
    Steiner JL, Norko M, Devine S, et al: Developing ethical guidelines for pharmaceutical company support in an academic mental health center. Psychiatr Serv 2003; 54: 1079–1089PubMedGoogle Scholar

Copyright information

© Academic Psychiatry 2005

Authors and Affiliations

  • Frederick Y. Huang
    • 1
  • Daniel S. Weiss
    • 1
  • Paul G. Fenimore
    • 1
  • Anne M. Fleming
    • 1
  • Ellen Haller
    • 1
  • Jonathan E. Lichtmacher
    • 1
  • Stuart J. Eisendrath
    • 1
  1. 1.Department of PsychiatryUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations